Quantitative analysis of LP-BM5 murine leukemia retrovirus RNA using real-time RT-PCR

被引:24
作者
Cook, WJ
Green, KA
Obar, JJ
Green, WR
机构
[1] Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA
[2] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
关键词
murine immunodeficiency; LP-BM5; MuLV; gag RNA; BM5def; BM5eco; real-time RT-PCR;
D O I
10.1016/S0166-0934(02)00256-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Murine AIDS (MAIDS) develops in susceptible mouse strains after infection with the LP-BM5 murine leukemia virus (MuLV) complex that contains a mixture of defective (BM5def) and replication-competent viruses. While the BM5def virus is the causative agent in MAIDS, the replication-competent viruses in LP-BM5, including ecotropic MuLV (BM5eco), are required for BM5def propagation and thus function as helper viruses. We describe quantitative real-time RT-PCR assays for RNA encoded by the BM5def and BM5eco components of LP-BM5. The assays were used to standardize better the input doses of LP-BM5 viruses across viral preparations and to quantify BM5def and BM5eco gag RNA levels in spleen and blood cells from MAIDS-susceptible and -insusceptible infected mice. Spleens of MAIDS-susceptible infected mice harbored approximately similar levels of BM5def gag RNA as infected spleens of mice that are insusceptible to MAIDS due to lack of CD40. In contrast, the same infected spleens of CD40-deficient mice contained substantially higher (up to 10-fold) levels of BM5eco gag RNA compared with susceptible controls. Similar to that seen in spleen, infected blood of CD40-deficient mice contained similar levels of BM5def gag as susceptible strains, but increased levels (up to threefold) of BM5eco gag RNA. The assays described below can be used to characterize better the contributions of different functional viral components of the LP-BM5 mixture to the development of MAIDS. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 46 条
  • [21] THE MAJORITY OF CELLS INFECTED WITH THE DEFECTIVE MURINE AIDS VIRUS BELONG TO THE B-CELL LINEAGE
    HUANG, M
    SIMARD, C
    KAY, DG
    JOLICOEUR, P
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (12) : 6562 - 6571
  • [22] SUSCEPTIBILITY OF INBRED STRAINS OF MICE TO MURINE AIDS (MAIDS) CORRELATES WITH TARGET-CELL EXPANSION AND HIGH EXPRESSION OF DEFECTIVE MAIDS VIRUS
    HUANG, M
    SIMARD, C
    JOLICOEUR, P
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (04) : 2398 - 2406
  • [23] MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (MAIDS) - AN ANIMAL-MODEL TO STUDY THE AIDS PATHOGENESIS
    JOLICOEUR, P
    [J]. FASEB JOURNAL, 1991, 5 (10) : 2398 - 2405
  • [24] KLINKEN SP, 1988, J IMMUNOL, V140, P1123
  • [25] KLINMAN DM, 1989, J IMMUNOL, V142, P1144
  • [26] Possible origin of murine AIDS (MAIDS) virus: Conversion of an endogenous retroviral p12(gag) sequence to a MAIDS-inducing sequence by frameshift mutations
    Kubo, Y
    Kakimi, K
    Higo, K
    Kobayashi, H
    Ono, T
    Iwama, Y
    Kuribayashi, K
    Hiai, H
    Adachi, A
    Ishimoto, A
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (09) : 6405 - 6409
  • [27] LEE JS, 1988, J VIROL, V69, P4182
  • [28] CHARACTERISTICS OF THE CELL-POPULATIONS INVOLVED IN EXTRA-THYMIC LYMPHOSARCOMA INDUCED IN C57BL-6 MICE BY RADLV-RS
    LEGRAND, E
    DACULSI, R
    DUPLAN, JF
    [J]. LEUKEMIA RESEARCH, 1981, 5 (03) : 223 - 233
  • [29] Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1 infected individuals on prolonged effective antiretroviral therapy
    Lewin, SR
    Vesanen, M
    Kostrikis, L
    Hurley, A
    Duran, M
    Zhang, L
    Ho, DD
    Markowitz, M
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (07) : 6099 - 6103
  • [30] MOLECULAR-CLONING OF INFECTIOUS INTEGRATED MURINE LEUKEMIA-VIRUS DNA FROM INFECTED-MOUSE CELLS
    LOWY, DR
    RANDS, E
    CHATTOPADHYAY, SK
    GARON, CF
    HAGER, GL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (01): : 614 - 618